No Tears for Johnson & Johnson, Still Remarkable
Published: Jul 18, 2012
After the earnings for Johnson & Johnson (JNJ) were released this morning, I was getting some of my dry powder ready to pounce. The pre-market had the shares down nearly 1.5%, as sales of $16.5 billion was down about 1% from last year. Not only that, sales were down in the U.S., as well as the rest of the world in total. In addition, there were currency issues that had a negative impact as well. As we always try to do with dividend investing, we were ready and able to gobble up some shares on the dip, which we thought would be dramatic. ?